Elevance Health Reports Third Quarter 2022 Results, Raises Full Year Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Elevance (ELV) PT Raised to $571 at Jefferies
October 20, 2022 8:48 AM EDTJefferies analyst David Windley raised the price target on Elevance (NYSE: ELV) to $571.00 (from $569.00) while maintaining a Buy rating.
The analyst commented, "LV's membership growth continues to be impressive, having eclipsed UNH in total members in the last 12 months. Government growth plus solid... More
Elevance Health Inc. (ELV) Tops Q3 EPS by 37c, Beats on Revenue
October 19, 2022 6:03 AM EDTElevance Health Inc. (NYSE: ELV) reported Q3 EPS of $7.53, $0.37 better than the analyst estimate of $7.16. Revenue for the quarter came in at $39.6 billion versus the consensus estimate of $39.26 billion.
GUIDANCE:
Elevance Health Inc. sees FY2022 EPS of $28.95.
For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.
... More